Free tool
FAERS Monitor: Vancomycin Hydrochloride In Plastic Container
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050671 or its brand name (Vancomycin Hydrochloride In Plastic Container, Vancomycin Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
7,339
Serious
6,612
90% of reports
Hospitalization
3,189
Death reported
1,453
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- drug ineffective850
- acute kidney injury498
- off label use460
- pyrexia433
- rash309
- drug reaction with eosinophilia and systemic symptoms300
- drug hypersensitivity289
- condition aggravated267
- pneumonia262
- diarrhoea255
- sepsis252
- hypotension225
- pruritus203
- dyspnoea202
- renal failure202
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 61 |
| 2005 | 51 |
| 2006 | 82 |
| 2007 | 150 |
| 2008 | 270 |
| 2009 | 99 |
| 2010 | 91 |
| 2011 | 106 |
| 2012 | 152 |
| 2013 | 196 |
| 2014 | 154 |
| 2015 | 265 |
| 2016 | 160 |
| 2017 | 180 |
| 2018 | 265 |
| 2019 | 387 |
| 2020 | 419 |
| 2021 | 628 |
| 2022 | 916 |
| 2023 | 918 |
| 2024 | 771 |
| 2025 | 653 |
| 2026 | 364 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,046,820 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| drug reaction with eosinophilia and systemic symptomsSignal | 300 | 33.8 | 30.2 | 9,416 |
| acute kidney injurySignal | 498 | 9.4 | 8.6 | 3,722 |
| sepsisSignal | 252 | 6.5 | 5.7 | 1,168 |
| renal failureSignal | 202 | 4.4 | 3.8 | 523 |
| drug hypersensitivitySignal | 289 | 4.3 | 3.8 | 730 |
| pyrexiaSignal | 433 | 3.6 | 3.3 | 819 |
| hypotensionSignal | 225 | 3.2 | 2.8 | 344 |
| condition aggravatedSignal | 267 | 2.5 | 2.2 | 246 |
| pneumoniaSignal | 262 | 2.3 | 2.1 | 198 |
| rashSignal | 309 | 2.0 | 1.8 | 164 |
| drug ineffective | 850 | 1.8 | 1.7 | 352 |
| pruritus | 203 | 1.5 | 1.3 | 36 |
| off label use | 460 | 1.5 | 1.4 | 81 |
| diarrhoea | 255 | 1.1 | 1.0 | 4 |
| dyspnoea | 202 | 1.0 | 0.9 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.